Lumos Pharma(LUMO) - 2020 Q4 - Annual Report
Lumos PharmaLumos Pharma(US:LUMO)2021-03-09 21:40
Transcript

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended December 31, 2020. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to . Commission File Number 001-35342 LUMOS PHARMA, INC. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorpora ...